NextCure, Inc. NXTC
Set alert
5.70 USD -0.61 -9.75%
At close · Nov 2
5.70 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
5.33 Day range 6.51
1.55 52-week range 15.74
- YTD
- -59.87%
- 1 year
- -54.80%
- Open
- 6.41
- Prev close
- 6.31
- Mkt cap
- 26.07M
- Vol
- 64.06K
- Avg vol
- 141.20K
- EPS
- -8.71
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.33
- High
- 6.51
- Forward P/E
- -0.66
- Beta
- 0.79
- Short ratio
- 1.89
- Inst. own
- 57.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 1, 2024
- 50-d avg
- 1.25
- 200-d avg
- 1.49
- 1y target
- 3.33
Analyst view
Consensus: none
Price target (mean) 3.33 -41.5% downside
Now 5.70
- Target (low)
- 3.00
- Target (mean)
- 3.33
- Target (high)
- 4.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy3
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.375 | -0.39 – -0.36 | -0.52 | +27.9% | 0 | 0.0% | 2 |
| Next quarter | -0.37 | -0.39 – -0.35 | -0.52199 | +29.1% | 0 | 0.0% | 2 |
| Current year | -1.97 | -1.97 – -1.97 | -2.25 | +12.4% | 0 | 0.0% | 1 |
| Next year | -1.45 | -1.52 – -1.38 | -1.97 | +26.4% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 2, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 3, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 22, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 20, 2024 | Needham | Maintained | Buy | Buy |
| Dec 14, 2023 | Needham | Maintained | Buy | Buy |
| Aug 8, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 4, 2023 | Needham | Reiterated | Buy | Buy |
| May 5, 2023 | Needham | Reiterated | — | Buy |
| Mar 3, 2023 | Needham | Reiterated | — | Buy |
| Nov 4, 2022 | Ladenburg Thalmann | Downgrade | Buy | Neutral |
| Nov 4, 2022 | Needham | Maintained | — | Buy |
| Nov 4, 2022 | Piper Sandler | Maintained | — | Overweight |
| Aug 23, 2022 | Truist Securities | Maintained | — | Buy |
| May 23, 2022 | Piper Sandler | Maintained | — | Overweight |
| Mar 1, 2022 | Ladenburg Thalmann | Initiated | — | Buy |
| Nov 5, 2021 | Needham | Maintained | — | Buy |
| Mar 5, 2021 | Truist Securities | Upgrade | Hold | Buy |
| Jan 15, 2021 | B of A Securities | Downgrade | Neutral | Underperform |
| Jul 16, 2020 | Benchmark | Upgrade | Hold | Buy |
| Jul 14, 2020 | BTIG | Maintained | — | Buy |
| Jul 13, 2020 | SunTrust Robinson Humphrey | Downgrade | Buy | Hold |
| Jun 1, 2020 | Benchmark | Downgrade | Buy | Hold |
| May 8, 2020 | Morgan Stanley | Maintained | — | Overweight |
| Apr 15, 2020 | Morgan Stanley | Maintained | — | Overweight |
| Mar 2, 2020 | Roth Capital | Initiated | — | Buy |
| Jan 13, 2020 | SunTrust Robinson Humphrey | Initiated | — | Buy |